AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Vicapsys Life Sciences Inc

Healthcare US VICP

0.444USD
-(-%)

Last update at 2024-05-15T13:30:00Z

Day Range

0.440.44
LowHigh

52 Week Range

1.003.00
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Minority interest - - - - -
Net income -1.66525M -0.76584M -0.76584M -1.40970M -2.20211M
Selling general administrative 0.63M 0.66M 0.66M 0.93M 2.48M
Selling and marketing expenses - - - - -
Gross profit - - - - 0.74M
Reconciled depreciation 0.03M 0.03M 0.03M 0.03M -
Ebit -0.98479M -0.76584M -0.76584M -1.03391M -1.28458M
Ebitda -0.27304M -0.73442M -0.73442M -1.00261M -
Depreciation and amortization 0.71M 0.03M - 0.03M -
Non operating income net other - - - - -
Operating income -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Other operating expenses 0.64M 0.77M - 1.03M -
Interest expense 0.68M 0.10M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M - 0.00000M 0.00000M -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.68M -0.10000M - 0.38M -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.74M
Total operating expenses 0.64M 0.77M 0.77M 1.03M 2.94M
Cost of revenue - - - - -
Total other income expense net -0.34023M 0.10M - - -
Discontinued operations - - - -0.37579M -0.91753M
Net income from continuing ops -0.98479M -0.23687M -0.76584M -1.03391M -2.20211M
Net income applicable to common shares -0.98834M -0.23687M -0.76584M -1.57018M -2.20211M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.07M 0.40M 0.40M 0.70M 0.80M
Intangible assets - 0.40M 0.40M 0.43M 0.47M
Earning assets - - - - -
Other current assets 0.06M 0.00550M - - -
Total liab 1.02M 0.85M 0.85M 0.40M 1.05M
Total stockholder equity -0.95079M -0.44911M -0.44911M 0.30M -0.26111M
Deferred long term liab - - - - -
Other current liab 0.12M 0.12M - - 0.70M
Common stock 0.03M 0.02M 0.02M 0.02M 0.00965M
Capital stock 0.03M 0.02M 0.02M 0.02M -
Retained earnings -15.11796M -13.89275M -13.89275M -13.12691M -11.55673M
Other liab - - - - -
Good will - - - - -
Other assets - - - - 0.24M
Cash 0.01M 0.00127M 0.00127M 0.26M 0.09M
Cash and equivalents - - - - -
Total current liabilities 1.02M 0.85M 0.85M 0.40M 1.05M
Current deferred revenue - - - - -
Net debt -0.01410M -0.00127M - -0.26417M -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 15.09M 13.42M 0.00065M 13.40M 0.00361M
Property plant equipment - - - - 0.21M
Total current assets 0.07M 0.00127M 0.00127M 0.26M 0.09M
Long term investments - - - - -
Net tangible assets -0.95079M -0.49317M -0.85940M -0.13976M -0.72669M
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.91M 0.74M 0.51M 0.40M 0.35M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.40M 0.40M 0.43M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M 0.10M 0.10M 0.10M 0.10M
Change to liabilities 0.27M -0.13726M 0.34M 0.05M -0.08396M
Total cashflows from investing activities - 0.10M 0.10M 0.10M -0.03802M
Net borrowings - - - - 0.18M
Total cash from financing activities 0.03M 0.56M 0.56M 1.15M 1.67M
Change to operating activities -0.00198M -0.00550M 0.12M 0.12M 0.02M
Net income -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Change in cash -0.20320M -0.26290M -0.26290M 0.18M -0.46127M
Begin period cash flow 0.22M 0.26M 0.26M 0.09M -
End period cash flow 0.01M 0.00127M 0.00127M 0.26M 0.09M
Total cash from operating activities -0.23820M -0.26290M -0.26290M -0.97026M -2.08867M
Issuance of capital stock 0.00000M 0.56M 0.00000M 0.97M -
Depreciation 0.03M 0.03M 0.03M 0.03M 0.13M
Other cashflows from investing activities - - - - -0.03802M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.03M 0.10M -0.01500M 0.18M 0.18M
Change to netincome 0.45M -0.09567M 0.01M 0.36M 0.06M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.27M 0.46M 0.46M 0.05M -
Stock based compensation 0.11M 0.01M 0.01M 0.12M -
Other non cash items 0.34M -0.10000M - -0.13283M -
Free cash flow -0.23820M -0.26290M -0.26290M -0.97026M -

Fundamentals

  • Previous Close 0.44
  • Market Cap87.88M
  • Volume0
  • P/E Ratio-
  • Dividend Yield9.60%
  • EBITDA-0.64086M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VICP
Vicapsys Life Sciences Inc
- -% 0.44 - - 0.004 0.03 0.84 -122.1975
NVO
Novo Nordisk A/S
-1.63 1.21% 133.03 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S
0.57 0.43% 132.69 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc
1.20 0.27% 438.69 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd
1.03 1.09% 96.00 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

Profile

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Cumming, Georgia.

Vicapsys Life Sciences Inc

7778 Mcginnis Ferry Road, Suwanee, GA, United States, 30024

Key Executives

Name Title Year Born
Mr. Federico Pier CEO, Exec. Chairman & Interim Pres 1968
Mr. Jeffery Wright CPA, CPA Chief Financial Officer 1983
Dr. Mark C. Poznansky M.D., Ph.D. Chief Scientist Advisor & Founder NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).